In MM, in vitro sensitivity to venetoclax from cell lines and primary samples has been analyzed in accordance to the expression of the anti-apoptotic proteins BCL-2, BCL-XL, and MCL-1 [23,55]. The gene discussed is BCL2L1; the disease is Miyoshi myopathy.